{"title":"Lumbar Intrathecal Injection in Adult and Neonatal Mice","authors":"Marina Stavrou, Elena Georgiou, Kleopas A. Kleopa","doi":"10.1002/cpz1.1091","DOIUrl":null,"url":null,"abstract":"<p>This article describes a step-by-step process of lumbar intrathecal injection of Evans blue dye and AAV9-EGFP in adult (2-month-old) and neonatal (postnatal day 10) mice. Intrathecal injection is a clinically translatable technique that has already been extensively applied in humans. In mice, intrathecal injection is considered a challenging procedure that requires a trained and experienced researcher. For both adult and neonatal mice, lumbar intrathecal injection is directed into the L5-L6 intervertebral space. Intrathecally injected material enters the cerebrospinal fluid (CSF) within the intrathecal space from where it can directly access the central nervous system (CNS) parenchyma. Simultaneously, intrathecally injected material exits the CSF with pressure gradient and enters the endoneurial fluid and ultimately the peripheral nerves. While in the CSF, the injectable material also enters the bloodstream and systemic circulation through the arachnoid villi. A successful lumbar intrathecal injection results in adequate biodistribution of the injectable material in the CNS, PNS, and peripheral organs. When correctly applied, this technique is considered as minimally invasive and non-disruptive and can be used for the lumbar delivery of any solute. © 2024 Wiley Periodicals LLC.</p><p><b>Basic Protocol 1</b>: C57BL/6 adult and P10 mice lumbar intrathecal injection</p><p><b>Basic Protocol 2</b>: Tissue collection and preparation for evaluating Evans blue dye diffusion</p><p><b>Basic Protocol 3</b>: Tissue collection and preparation for immunohistochemistry staining</p><p><b>Basic Protocol 4</b>: Tissue collection and vector genome copy number analysis</p>","PeriodicalId":93970,"journal":{"name":"Current protocols","volume":"4 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current protocols","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cpz1.1091","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This article describes a step-by-step process of lumbar intrathecal injection of Evans blue dye and AAV9-EGFP in adult (2-month-old) and neonatal (postnatal day 10) mice. Intrathecal injection is a clinically translatable technique that has already been extensively applied in humans. In mice, intrathecal injection is considered a challenging procedure that requires a trained and experienced researcher. For both adult and neonatal mice, lumbar intrathecal injection is directed into the L5-L6 intervertebral space. Intrathecally injected material enters the cerebrospinal fluid (CSF) within the intrathecal space from where it can directly access the central nervous system (CNS) parenchyma. Simultaneously, intrathecally injected material exits the CSF with pressure gradient and enters the endoneurial fluid and ultimately the peripheral nerves. While in the CSF, the injectable material also enters the bloodstream and systemic circulation through the arachnoid villi. A successful lumbar intrathecal injection results in adequate biodistribution of the injectable material in the CNS, PNS, and peripheral organs. When correctly applied, this technique is considered as minimally invasive and non-disruptive and can be used for the lumbar delivery of any solute. © 2024 Wiley Periodicals LLC.
Basic Protocol 1: C57BL/6 adult and P10 mice lumbar intrathecal injection
Basic Protocol 2: Tissue collection and preparation for evaluating Evans blue dye diffusion
Basic Protocol 3: Tissue collection and preparation for immunohistochemistry staining
Basic Protocol 4: Tissue collection and vector genome copy number analysis
成年小鼠和新生小鼠的腰椎鞘内注射
本文介绍了在成年(2 个月大)和新生儿(出生后第 10 天)小鼠腰部鞘内注射埃文斯蓝染料和 AAV9-EGFP 的逐步过程。鞘内注射是一种可应用于临床的技术,已广泛应用于人类。在小鼠中,鞘内注射被认为是一项具有挑战性的程序,需要训练有素、经验丰富的研究人员来完成。无论是成年小鼠还是新生小鼠,腰椎腔内注射都是针对 L5-L6 椎间隙。鞘内注射的物质进入鞘内间隙的脑脊液(CSF),从那里可直接进入中枢神经系统(CNS)实质。同时,鞘内注射材料会随着压力梯度流出脑脊液,进入神经内液,最终进入周围神经。在脑脊液中,注射材料还会通过蛛网膜绒毛进入血液和全身循环。成功的腰椎腔内注射可使注射材料在中枢神经系统、前列腺神经系统和外周器官中充分的生物分布。如果应用得当,这种技术被认为是微创和无破坏性的,可用于任何溶质的腰部给药。© 2024 Wiley Periodicals LLC.基本方案 1:C57BL/6 成年小鼠和 P10 小鼠腰部鞘内注射 基本方案 2:组织收集和用于评估伊文思蓝染料扩散的准备 基本方案 3:组织收集和用于免疫组化染色的准备 基本方案 4:组织收集和载体基因组拷贝数分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。